ReviewJournal of dental research, dental clinics, dental prospects2025
Survival and prognostic factors in mucosal melanomas of the oral cavity: A meta-analysis.
Review in Journal of dental research, dental clinics, dental prospects, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stage-Adapted Cryotherapy-Based Management of Oral Mucosal Melanoma: A Single-Center Retrospective Cohort.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The development of early metastases due to the high vascularization and lymphatic drainage of the oral cavity, followed by delayed diagnosis, results in a worse prognosis of oral melanomas. The present study aimed to determine the survival of oral melanoma in different periods and analyze its prognostic factors. Methods: A search for studies on survival and prognostic factors of oral melanoma was performed in the following databases: PubMed (MEDLINE, Cochrane Library), Web of Science (WoS), and Scopus. The estimation of the pooled proportion was carried out with the generic inverse variance method, using the standard error (SE) of the proportion. For dichotomous outcomes, the estimates of the effects of the intervention were expressed as odds ratios (ORs) using the Mantel-Haenszel (M-H) method, all with 95% confidence intervals. Results: Thirty-eight studies that considered 3767 oral melanoma patients were included in this meta-analysis. Overall survival (OS) decreased from 58% at two years to 42% at three years and 29% at five years. Regarding prognostic factors, non-ulcerated oral melanomas with a high degree of pigmentation showed the best survival at 5 years. In contrast, oral tumor location and gender did not significantly affect oral melanoma survival. Conclusion: Oral melanoma has a low survival rate, with ulcerated and poorly pigmented tumors having the worst prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.